Get access to our best features
Get access to our best features
Published 2 years ago

Vir Biotechnology Wins US Contract Worth Up to $1 Billion (2)

Summary by Ground News
Government agency to initially invest $55 million in flu drugContract would fund Vir to develop needed countermeasures. Vir Biotechnology Inc., the collaborator with GSK Plc on a Covid-19 treatment, won a multiyear contract to help the US government prepare for future pandemics.

0 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Ground News Article Assistant
Not enough coverage to generate an Article Assistant.

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics